Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study

BMC Neurology

Volumn 10, Issue 1, 2010, Pages

  Boles, Richard G ^a,b   Lovett Barr, Mary R ^c   Preston, Amy ^c   Li, B U K ^d   Adams, Kathleen ^c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Cyclic Vomiting Syndrome Association   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARNITINE; UBIDECARENONE; ANTIEMETIC AGENT; DRUG DERIVATIVE; UBIQUINONE;

ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; UNSPECIFIED SIDE EFFECT; VOMITING; COMPARATIVE STUDY; INTERNET; ONSET AGE; PARENT; PERIODICITY; RISK ASSESSMENT; SYNDROME; TREATMENT OUTCOME;

AGE OF ONSET; AMITRIPTYLINE; ANTIEMETICS; HUMANS; INTERNET; PARENTS; PATIENT SATISFACTION; PERIODICITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SYNDROME; TREATMENT OUTCOME; UBIQUINONE; VOMITING;

EID: 77349117316     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-10     Document Type: Article

References (32)

1. Li BUK, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, Linder SL, Issenman RM, Rudolph CD. NASPGHAN Consensus Statement on the Diagnosis and Management of CVS. J Pediatr Gastroenterol Nutr 2008, 47(3):379-393. 10.1097/MPG.0b013e318173ed39, 18728540.
2. Abu-Arafeh I, Russell G. Cyclical vomiting syndrome in children: a population-based study. J Pediatr Gastroenterol Nutr 1995, 21(4):454-458.
3. Cullen K, Macdonald WB. The periodic syndrome. Its nature and prevalence. Med J Australia 1963, 50(2):167-172.
4. Li BUK, Murray RD, Heitlinger LA, Robbins JL, Hayes JR. Is cyclic vomiting syndrome related to migraine?. J Pediatr 1999, 134(5):567-572. 10.1016/S0022-3476(99)70242-8, 10228291.
5. Anderson JM, Sugerman KS, Lockhart JR, Weinberg WA. Effective prophylactic therapy for cyclic vomiting syndrome in children using amitriptyline or cyproheptadine. Pediatrics 1997, 100(6):977-981. 10.1542/peds.100.6.977, 9374568.
6. Prakash C, Clouse R. Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressents. Am J Gastroenterol 1999, 94(10):2856-2860.
7. Boles RG, Powers AL, Adams K. Cyclic vomiting syndrome plus. J Child Neurol 2006, 21(3):182-188.
8. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. The metabolic and molecular bases of inherited disease 1995, 1535-629. New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, 7.
9. Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology 2005, 64(4):713-715.
10. Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J 2006, 27(22):2675-2681. 10.1093/eurheartj/ehl158, 16882678.
11. Berthold HK, Naini A, Di Mauro S, Hallikainen M, Gylling H, Krone W, Gouni-Berthold I. Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma: A Randomised Trial. Drug Saf 2006, 29(8):703-712. 10.2165/00002018-200629080-00007, 16872244.
12. Beal MF. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. J Bioenerg Biomembr 2004, 36(4):381-386. 10.1023/B:JOBB.0000041772.74810.92, 15377876.
13. Wong L-JC, Boles RG. Mitochondrial DNA Analysis in Clinical Laboratory Diagnostics. Clin Chim Acta 2005, 354:1-20. 10.1016/j.cccn.2004.11.003, 15748595.
14. Montagna P, Cortelli P, Monari L, Pierangeli G, Parchi P, Lodi R, Iotti S, Frassineti C, Zaniol P, Lugaresi E, et al. 31P-magnetic resonance spectroscopy in migraine without aura. Neurology 1994, 44(4):666-669.
15. Montagna P, Sacquegna T, Martinelli P, Cortelli P, Bresolin N, Moggio M, Baldrati A, Riva R, Lugaresi E. Mitochondrial abnormalities in migraine. Preliminary findings. Headache 1988, 28(7):477-480. 10.1111/j.1526-4610.1988.hed2807477.x, 3243709.
16. Sangiorgi S, Mochi M, Riva R, Cortelli P, Monari L, Pierangeli G, Montagna P. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia 1994, 14(1):21-23. 10.1046/j.1468-2982.1994.1401021.x, 8200018.
17. Boles RG, Williams JC. Mitochondrial Disease and Cyclic Vomiting Syndrome. Dig Dis Sci 1999, 44(Suppl):103S-107S.
18. Majamaa K, Finnilä, Turkka J, Hassinen IE. Mitochondrial DNA haplotype U as a risk factor for occipital stroke in migraine. Lancet 1998, 352(9126):455-456. 10.1016/S0140-6736(05)79190-X, 9708761.
19. Shimomura T, Kitano A, Marukawa H, Takahashi K. Mutation in platelet mitochondrial gene in patients with migraine. Cephalalgia 1995, 15(Suppl 13):10.
20. Boles RG, Chun N, Senadheera D, Wong L-JC. Cyclic vomiting syndrome and mitochondrial DNA mutations. Lancet 1997, 350(9087):1299-300. 10.1016/S0140-6736(05)62477-4, 9357417.
21. Ojaimi J, Katsabanis S, Bower S, Quigley A, Byrne E. Mitochondrial DNA in stroke and migraine with aura. Cerebrovasc Dis 1998, 8(2):102-106. 10.1159/000015826, 9548008.
22. Wang Q, Ito M, Adams K, Li BU, Klopstock T, Maslim A, Higashimoto T, Herzog J, Boles RG. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome. Am J Med Gene At 2004, 131(1):50-58.
23. Zaki EA, Freilinger T, Klopstock T, Baldwin EE, Heisner K, Adams K, Dichgans M, Wagler S, Boles RG. Two Common Mitochondrial DNA Polymorphisms Are Highly Associated With Migraine Headache and Cyclic Vomiting Syndrome. Cephalalgia 2009, 29(7):719-728. 10.1111/j.1468-2982.2008.01793.x, 19220304.
24. Couch JR, Bearss C, Verhulst S. Importance of maternal heredity in the etiology of migraine. Neurology 1986, 36(Suppl 1):99.
25. Mortimer MJ, Kay J, Jaron A, Good PA. Does a history of maternal migraine or depression predispose children to headache and stomach-ache?. Headache 1992, 32(7):353-355. 10.1111/j.1526-4610.1992.hed3207353.x, 1526767.
26. Boles RG, Adams K, Ito M, Li BU. Maternal inheritance in cyclic vomiting syndrome with neuromuscular disease. Am J Med Genet 2003, 120A(4):474-482. 10.1002/ajmg.a.20126, 12884425.
27. Boles RG, Adams K, Li BU. Maternal inheritance in cyclic vomiting syndrome. Am J Med Genet 2005, 133A(1):71-77. 10.1002/ajmg.a.30524, 15643622.
28. Drossman DA, Corazziari E, Delvaux M, Spiller R, Talley NJ, Thompson WG, Whitehead WE. Rome III: The Functional Gastrointestinal Disorders 2006, McLean, VA: Degnon Associates, 3.
29. Abell TL, Adams KA, Boles RG, Bousvaros A, Chong SK, Fleischer DR, Hasler WL, Hyman PE, Issenman RM, Li BU, Linder SL, Mayer EA, McCallum RW, Olden K, Parkman HP, Rudolph CD, Taché Y, Tarbell S, Vakil N. Cyclic vomiting syndrome in adults. Neurogastroenterol Motil 2008, 20(4):269-284. 10.1111/j.1365-2982.2008.01113.x, 18371009.
30. Boles RG, Zaki EA, Lavenbarg T, Hejazi R, Foran P, Freeborn J, Trilokekar S, McCallum R. Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A. Neurogastroenterol Motil 2009, 21(9):936-e72. 10.1111/j.1365-2982.2009.01305.x, 19368653.
31. Van Calcar SC, Harding CO, Wolff JA. L-carnitine administration reduces number of episodes in cyclic vomiting syndrome. Clin Pediatr (Phila) 2002, 41(3):171-174. 10.1177/000992280204100307, 11999680.
32. Boehnke C, Reuter U, Flach U, Schuh-Hofer S, Einhäupl K, Arnold G. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004, 11(7):475-477. 10.1111/j.1468-1331.2004.00813.x, 15257686.